In March 2025, the company declared new strategies to get a direct-to-client offering of its Wegovy weight loss drug. The company set up a new pharmacy, named NovoCare, which would charge clients $499 every month for entry to the drug, a lot less than 50 % the cost of the drug by way of other pharmaceutical distribution networks.[fifty three]Issues